A ccording to preliminary estimates, Light Vehicle (LV) sales grew by 2.4% year-on-year (YoY) in December, to 1.51 million ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Thanks to the expected introduction of several late-stage pipeline products. The type 1 diabetes (T1D) market across the ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

The heart failure market is expected to grow at a 9.6% CAGR from $13.5bn in 2022 to $33.7bn in 2032 in the 7MM.

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox ...